R & D to develop Execabase to combat S. aureus

Award NoticeAwarded

This federal contract opportunity has been awarded to on March 10, 3031.

Award Information

This solicitation resulted in an award to for approximately $86,807,228 on March 10, 3031. Similar contracts are typically issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF under 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Award Number: 75A50121C00021
Award Amount: $86,807,228
Award Date: March 10, 3031

View full award details on USASpending.gov

Key Takeaways

No response deadline specified - contact the agency for details
Full and open competition - all businesses eligible to bid
Work to be performed in WASHINGTON, DC
Industry: Research and Development in Biotechnology (except Nanobiotechnology)

Contract Details

Notice ID: 21C00021
Opportunity Type: Award Notice
Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-Agency: OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office: BARDA - ASPR / DAAPPO / BARDA DCMA
Posted Date: Thursday, March 11, 2021
Response Deadline: Not specified
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC Code: 6515
Set-Aside: Full & Open Competition
Place of Performance: WASHINGTON, DC, 20515
Status: Active

View on SAM.gov

Description

Not fixed price and not competetive. Negotiated award based on Broad Agency Announcement

Why This Opportunity Matters

HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for research and development in biotechnology (except nanobiotechnology) in WASHINGTON, DC.

Similar Opportunities

AJ11-VA Depleted Uranium Program PO 512C50314

VETERANS AFFAIRS, DEPARTMENT OF•MD

Q-RNAscope In-House Assay

HEALTH AND HUMAN SERVICES, DEPARTMENT OF•MD

Low-cost, Connected, Digital Lateral Flow Platform to Detect Influenza A, Influenza B, and SARS-Cov -2 for use in Over-the-Counter (OTC) Settings

HEALTH AND HUMAN SERVICES, DEPARTMENT OF•DC

A-High Throughput Transcriptomics (HTTr)

ENVIRONMENTAL PROTECTION AGENCY•OH

human-derived monoclonal antibodies (mAbs) and viral recombinant antigens (Ags)

DEPT OF DEFENSE•MD

Browse Related

More from HEALTH AND HUMAN SERVICES, DEPARTMENT OF

View all contracts from this agency

Contracts in DC

Browse opportunities in this state

Research and Development in Biotechnology (except Nanobiotechnology)

NAICS 541714 contracts

Looking for more opportunities?

Browse our full directory of government contracts

View All Contracts